Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06688188 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study

Name: 68Ga-JH12 PET/CT: Dosimetry and Biodistribution Study — clinical trial record (NCT06688188)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseEarly Phase 1

SponsorFirst Affiliated Hospital of Fujian Medical University

Started2024-11-01

View on ClinicalTrials.gov ↗

Record status

This record was last updated November 14, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.

First Affiliated Hospital of Fujian Medical University

56 trials monitored

See all monitored trials

68Ga-JH12 is a novel radiotracer targeting C-X-C motif chemokine receptor 4 (CXCR4). In this study, we observed the safety, biodistribution, and radiation dosimetry of 68Ga-JH12 in patients with different types of cancer.

Trial Details

NCT Number	NCT06688188
Lead Sponsor	First Affiliated Hospital of Fujian Medical University
Conditions	Malignant Neoplasm
Enrollment	5 participants
Start Date	2024-11-01
Primary Completion	2025-06-30 (estimated)
Study Completion	2025-12-31 (estimated)
Updated on ClinicalTrials.gov	2024-11-14